Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

PBRM1 Deficiency Confers Synthetic Lethality to DNA Repair Inhibitors in Cancer
Roman M. Chabanon, Daphné Morel, Thomas Eychenne, et al.
Cancer Research (2021) Vol. 81, Iss. 11, pp. 2888-2902
Open Access | Times Cited: 85

Showing 1-25 of 85 citing articles:

Targeting the DNA damage response in immuno-oncology: developments and opportunities
Roman M. Chabanon, Mathieu Rouanne, Christopher J. Lord, et al.
Nature reviews. Cancer (2021) Vol. 21, Iss. 11, pp. 701-717
Closed Access | Times Cited: 211
The expanding universe of PARP1-mediated molecular and therapeutic mechanisms
Dan Huang, W. Lee Kraus
Molecular Cell (2022) Vol. 82, Iss. 12, pp. 2315-2334
Open Access | Times Cited: 158
Walking a tightrope: The complex balancing act of R-loops in genome stability
Joshua R. Brickner, Jada L. Garzon, Karlene A. Cimprich
Molecular Cell (2022) Vol. 82, Iss. 12, pp. 2267-2297
Open Access | Times Cited: 149
Radiotherapy as a tool to elicit clinically actionable signalling pathways in cancer
Giulia Petroni, Lewis C. Cantley, Laura Santambrogio, et al.
Nature Reviews Clinical Oncology (2021) Vol. 19, Iss. 2, pp. 114-131
Open Access | Times Cited: 138
Targeting oncogene and non-oncogene addiction to inflame the tumour microenvironment
Giulia Petroni, Aitziber Buqué, Lisa M. Coussens, et al.
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 6, pp. 440-462
Closed Access | Times Cited: 96
The DNA Damage Response and Inflammation in Cancer
Vanessa Klapp, Beatriz Álvarez-Abril, Giuseppe Leuzzi, et al.
Cancer Discovery (2023) Vol. 13, Iss. 7, pp. 1521-1545
Open Access | Times Cited: 54
Targeting ATR in patients with cancer
Natalie Ngoi, Patrick G. Pilié, Daniel J. McGrail, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 4, pp. 278-293
Closed Access | Times Cited: 21
New Horizons of Synthetic Lethality in Cancer: Current Development and Future Perspectives
Viola Previtali, Greta Bagnolini, Andrea Ciamarone, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 14, pp. 11488-11521
Open Access | Times Cited: 15
Defining R-loop classes and their contributions to genome instability
Daisy Castillo-Guzman, Frédéric Chédin
DNA repair (2021) Vol. 106, pp. 103182-103182
Open Access | Times Cited: 74
Immunotherapy for SMARCB1-Deficient Sarcomas: Current Evidence and Future Developments
Carine Ngo, Sophie Postel‐Vinay
Biomedicines (2022) Vol. 10, Iss. 3, pp. 650-650
Open Access | Times Cited: 40
RAD51AP1 regulates ALT-HDR through chromatin-directed homeostasis of TERRA
Nicole Kaminski, Anne R. Wondisford, Youngho Kwon, et al.
Molecular Cell (2022) Vol. 82, Iss. 21, pp. 4001-4017.e7
Open Access | Times Cited: 39
Combining targeted DNA repair inhibition and immune-oncology approaches for enhanced tumor control
Kyle Concannon, Benjamin B. Morris, Carl M. Gay, et al.
Molecular Cell (2023) Vol. 83, Iss. 5, pp. 660-680
Open Access | Times Cited: 27
ARID1A regulates DNA repair through chromatin organization and its deficiency triggers DNA damage-mediated anti-tumor immune response
Ali Bakr, G Corte, Olivera Veselinov, et al.
Nucleic Acids Research (2024) Vol. 52, Iss. 10, pp. 5698-5719
Open Access | Times Cited: 12
PSIP1/LEDGF reduces R-loops at transcription sites to maintain genome integrity
Sundarraj Jayakumar, Manthan Patel, Fanny Boulet, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 10
The molecular code of kidney cancer: A path of discovery for gene mutation and precision therapy
Deqian Xie, Guandu Li, Zhonghua Zheng, et al.
Molecular Aspects of Medicine (2025) Vol. 101, pp. 101335-101335
Open Access | Times Cited: 1
The Interplay Between Chromatin Remodeling and DNA Double-strand Break Repair: Implications for Cancer Biology and Therapeutics
Liu‐Jun He, Jaeyoung Moon, Chenghui Cai, et al.
DNA repair (2025) Vol. 146, pp. 103811-103811
Open Access | Times Cited: 1
PBRM1, SETD2 and BAP1 — the trinity of 3p in clear cell renal cell carcinoma
Joseph Walton, Keith A. Lawson, Panagiotis Prinos, et al.
Nature Reviews Urology (2022) Vol. 20, Iss. 2, pp. 96-115
Closed Access | Times Cited: 33
Inflammatory Networks in Renal Cell Carcinoma
Linus Kruk, Medina Mamtimin, Attila Braun, et al.
Cancers (2023) Vol. 15, Iss. 8, pp. 2212-2212
Open Access | Times Cited: 16
Chromatin Remodelers Are Regulators of the Tumor Immune Microenvironment
Apoorvi Chaudhri, Gregory Lizée, Patrick Hwu, et al.
Cancer Research (2024) Vol. 84, Iss. 7, pp. 965-976
Closed Access | Times Cited: 6
Targeting Chromatin-Remodeling Factors in Cancer Cells: Promising Molecules in Cancer Therapy
Fang-Lin Zhang, Da‐Qiang Li
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 12815-12815
Open Access | Times Cited: 27
RNase H1, the Gold Standard for R-Loop Detection
Susana M. Cerritelli, Kiran Sakhuja, Robert J. Crouch
Methods in molecular biology (2022), pp. 91-114
Closed Access | Times Cited: 26
Molecular Characterization of Mesothelioma: Impact of Histologic Type and Site of Origin on Molecular Landscape
Ibiayi Dagogo‐Jack, Russell W. Madison, Jochen K. Lennerz, et al.
JCO Precision Oncology (2022), Iss. 6
Closed Access | Times Cited: 23
SWI/SNF complex gene variations are associated with a higher tumor mutational burden and a better response to immune checkpoint inhibitor treatment: a pan-cancer analysis of next-generation sequencing data corresponding to 4591 cases
Yue Li, Xinhua Yang, Weijie Zhu, et al.
Cancer Cell International (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 22
DNA Repair Deficiency Regulates Immunity Response in Cancers: Molecular Mechanism and Approaches for Combining Immunotherapy
Yi Xu, Somaira Nowsheen, Min Deng
Cancers (2023) Vol. 15, Iss. 5, pp. 1619-1619
Open Access | Times Cited: 14
R-Loops and R-Loop-Binding Proteins in Cancer Progression and Drug Resistance
Noha Elsakrmy, Haissi Cui
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7064-7064
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top